Results 331 to 340 of about 774,384 (405)

Oral Pulmonary Arterial Hypertension-Targeted Therapy in Patients With Pulmonary Hypertension due to Interstitial Lung Disease

Kavitha Selvan, Krittika Teerapuncharoen, Remzi Bag   +2 more
openalex   +2 more sources

Optimizing the integration of modern systemic therapies and advanced radiotherapy techniques in breast cancer management: An expert opinion from the Institut Curie Breast Radiotherapy Group

International Journal of Cancer, EarlyView.
Abstract The integration of modern systemic therapies with radiotherapy (RT) represents a promising strategy in breast cancer management, enhancing both locoregional control and systemic disease outcomes. This expert consensus from the Institut Curie Breast Radiotherapy Group focuses exclusively on modern systemic agents, synthesizing current evidence ...
Cezara Cheptea, Pierre Loap, Sofiane Allali, Alain Fourquet, Kim Cao, Youlia Kirova   +5 more
wiley   +1 more source

A screening tool to detect interstitial lung disease in systemic sclerosis: the ILD-RISC score. [PDF]

Rheumatology (Oxford)
Bruni C, Tofani L, Fretheim H, Liem SIE, Velauthapillai A, Bjørkekjær H, Barua I, Galetti I, Garaiman A, Becker MO, Hoffmann-Vold AM, de Vries-Bouwstra J, Vonk MC, Distler JHW, Matucci-Cerinic M, Distler O.   +15 more
europepmc   +1 more source

Clinical trial of safety and antitumor activity of farletuzumab ecteribulin in patients with platinum‐resistant ovarian cancer: Phase I expansion results

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective In the dose‐escalation part of Study 101, which included multiple tumor types, objective responses were observed in 10 of 22 patients across multiple dose levels of farletuzumab ecteribulin (FZEC). We explored the safety/antitumor activity of FZEC in patients with platinum‐resistant ovarian cancer (PROC) from the Study 101 expansion ...
Kan Yonemori, Mayu Yunokawa, Koji Matsumoto, Kazuhiro Takehara, Kosei Hasegawa, Yasuyuki Hirashima, Hidenori Kato, Hiroki Ikezawa, Yohei Otake, Wataru Yusa, Takuma Miura, Shin Nishio   +11 more
wiley   +1 more source

Beyond Labels: Can Biomarkers and Treatable Traits Revolutionize Interstitial Lung Disease Care? [PDF]

Biomedicines
Amati F, Stainer A, Aliberti S.
europepmc   +1 more source

CellOntologyMapper: Consensus mapping of cell type annotation

iMetaOmics, EarlyView.
CellOntologyMapper automates the standardization of cell type annotations in single‐cell RNA‐seq by mapping user‐defined names to the Cell Ontology (CL) and Cell Taxonomy (CT). The framework constructs a comprehensive embedding database of 19,381 curated cell types using sentence transformers, large language models, and synonym expansion.
Zehua Zeng, Xuehai Wang, Hongwu Du, Cencan Xing   +3 more
wiley   +1 more source

The Great Mimicker: Pulmonary Adenocarcinoma with Interstitial Lung Disease-Like Presentation. [PDF]

Eur J Case Rep Intern Med
Upadhyay M, Shanker P, Joshi S, Khan U.
europepmc   +1 more source

Microvascular obstruction in cardiac amyloidosis

European Journal of Heart Failure, EarlyView.
Lucrezia Netti, Adam Ioannou, Ana Martinez‐Naharro, Yousuf Razvi, Aldostefano Porcari, Lucia Venneri, Viviana Maestrini, Dan Knight, Ruta Virsinskaite, Muhammad U. Rauf, Tushar Kotecha, Rishi K. Patel, Ashutosh Wechelakar, Helen Lachmann, Peter Kellman, Charlotte Manisty, James Moon, Philip N. Hawkins, Julian D. Gillmore, Marianna Fontana   +19 more
wiley   +1 more source

Evaluation of screening methods for preclinical interstitial lung disease associated with rheumatoid arthritis. [PDF]

J Bras Pneumol
Almeida ALB, Lima MDM, Guimarães MFBR, Mancuzo EV.   +3 more
europepmc   +1 more source

Rheumatoid arthritis-associated interstitial lung disease: clinical predictive model and external validation. [PDF]

Respir Res
Yao C, Lu Y, Dou D, Xia C, Ma X, Yang Y, Xu H, Liu W, Song M, Yang J, Jiao J, Tang X, Gong X, Gao G, Yang J, Jiang Q.   +15 more
europepmc   +1 more source